http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001011133-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40a92325286ca98dbffa06d2c67ed064 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
filingDate | 2001-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8561832020c0ae2bef2c75502f0f3a20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5af36f1153a33c5f5706ef5dea07f371 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b6a6b92276cd886e73c21004d2f4c79 |
publicationDate | 2001-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2001011133-A1 |
titleOfInvention | Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands |
abstract | Disclosed are compounds of the formula: n n n or the pharmaceutically acceptable non-toxic salts thereof where R 1 -R 4 and A are defined herein, which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors and are, therefore, useful in the diagnosis and treatment of anxiety, Down Syndrome, depression, sleep, cognitive and seizure disorders, overdose with benzodiazepine drugs and for enhancement of alertness. |
priorityDate | 1998-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 669.